SAN DIEGO – Resmed has introduced the Sleep Institute, a worldwide clinical insights initiative designed to advance the science and understanding of sleep health.
The Sleep Institute collaborates with clinicians, researchers, policymakers and health system leaders to provide objective, evidence-based insights—independent of commercial influence—that inform innovation in care, support policy development, and elevate sleep as a global health priority.
“Sleep Institute reflects Resmed’s commitment to advancing sleep health worldwide,” said Kimberly L. Sterling, vice president of health research at Resmed, speaking on behalf of the initiative. “It’s about moving from awareness to action—giving global health and policy leaders the insights they need to close today’s care gaps and shape tomorrow’s sleep medicine.”
Findings from a recent U.S. consumer survey by the Sleep Institute underscore the need for this work: while more than 80% of respondents said sleep is vital to overall health, only one in three reported that a doctor or nurse had asked about their sleep within the past six months. This disconnect, the institute notes, highlights the importance of integrating sleep more fully into routine health care and policy discussions.
Global debut at World Sleep Congress
The Sleep Institute will officially launch at the World Sleep Congress, Sept. 5–10 in Singapore, with an expert-led symposium addressing one of the field’s most pressing issues: the global underdiagnosis of obstructive sleep apnea (OSA).
The session, OSA Underdiagnosis – A world of difference, a common challenge, will explore barriers in diagnostic pathways and spotlight scalable solutions to improve access and outcomes. Speakers include international leaders in sleep medicine:
- Erna Sif Arnardóttir – director, Reykjavik University Sleep Institute; president, European Sleep Research Society (Iceland)
- Chi-Hang Ronald Lee – professor of medicine, National University of Singapore; senior consultant, National University Heart Centre and Alexandra Hospital (Singapore)
- Michelle R. Zeidler – professor of medicine, UCLA; director, VA Greater Los Angeles Sleep Center (U.S.)
- Ludger Grote – medical director, Sleep Disorders Center, Sahlgrenska University Hospital (Sweden)
“There is a clear and urgent need to close the diagnosis gap in sleep disorders such as OSA,” said Michelle R. Zeidler, MD. “The Sleep Institute’s focus on translating evidence into action will help clinicians, policymakers, and health systems take meaningful steps toward earlier detection and more personalized care.”
